Hsu YC - Search Results

1

Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing.

Huang CC, Liu CY, Huang CJ, Hsu YC, Lien HH, Wong JU, Tai FC, Ku WH, Hung CF, Lin JT, Huang CS, Chiang HS. Huang CC, et al. Among authors: hsu yc. Int J Mol Sci. 2022 Jan 29;23(3):1579. doi: 10.3390/ijms23031579. Int J Mol Sci. 2022. PMID: 35163506 Free PMC article.

2

Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?

Hsu YC, Liou JM, Yang TH, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS. Hsu YC, et al. Among authors: hsu wl. J Gastroenterol. 2011 Feb;46(2):183-90. doi: 10.1007/s00535-010-0334-1. Epub 2010 Oct 19. J Gastroenterol. 2011. PMID: 20957498 Clinical Trial.

3

Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?

Hsu YC, Yang TH, Liou JM, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS. Hsu YC, et al. Among authors: hsu wl. Dig Liver Dis. 2012 Mar;44(3):218-23. doi: 10.1016/j.dld.2011.10.012. Epub 2011 Nov 23. Dig Liver Dis. 2012. PMID: 22115792

4

Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia.

Hsu YC, Chiu HM, Liou JM, Chang CC, Lin JT, Liu HH, Wu MS. Hsu YC, et al. Cancer Causes Control. 2012 Feb;23(2):321-8. doi: 10.1007/s10552-011-9880-y. Epub 2011 Nov 29. Cancer Causes Control. 2012. PMID: 22124615

5

Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation.

Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT. Hsu YC, et al. Among authors: hsu cc, hsu cy. Antivir Ther. 2012;17(4):605-12. doi: 10.3851/IMP2027. Epub 2011 Dec 20. Antivir Ther. 2012. PMID: 22301517

6

Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study.

Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Hsu YC, et al. Hepatology. 2012 Aug;56(2):698-705. doi: 10.1002/hep.25684. Epub 2012 Jul 6. Hepatology. 2012. PMID: 22378148

7

Images in clinical medicine. Intestinal infestation with Ancylostoma ceylanicum.

Hsu YC, Lin JT. Hsu YC, et al. N Engl J Med. 2012 Mar 29;366(13):e20. doi: 10.1056/NEJMicm1101717. N Engl J Med. 2012. PMID: 22455438 Free article. No abstract available.

8

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

Liou JM, Chen CC, Chang CY, Chen MJ, Fang YJ, Lee JY, Chen CC, Hsu SJ, Hsu YC, Tseng CH, Tseng PH, Chang L, Chang WH, Wang HP, Shun CT, Wu JY, Lee YC, Lin JT, Wu MS; Taiwan Helicobacter Consortium. Liou JM, et al. Among authors: hsu yc, hsu sj. J Antimicrob Chemother. 2013 Feb;68(2):450-6. doi: 10.1093/jac/dks407. Epub 2012 Oct 25. J Antimicrob Chemother. 2013. PMID: 23099849 Clinical Trial.

9

Pretreatment viral DNA stratifies mortality risk in patients receiving antiviral therapy for severe acute exacerbation of chronic hepatitis B.

Hsu YC, Wu CY, Chang CY, Tai CM, Tseng CH, Perng DS, Mo LR, Lin JT. Hsu YC, et al. Antivir Ther. 2013;18(2):221-8. doi: 10.3851/IMP2435. Epub 2012 Nov 6. Antivir Ther. 2013. PMID: 23128388

10

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.

Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT. Wu CY, et al. Among authors: hsu yc. JAMA. 2012 Nov 14;308(18):1906-14. doi: 10.1001/2012.jama.11975. JAMA. 2012. PMID: 23162861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,449 results

Search Page